|
|
Application effect of Xuanyu Tongjing Decoction combined with gonadotropin-releasing hormone agonist in the postoperative patients with ovarian endometriosis |
WANG Shuang AI Xiao-yan▲ YUAN Yuan MEI Tong XIONG Xiang-peng |
Department of Gynecology,JiangxiMaternal and Child Health Hospital,Nanchang 330006,China |
|
|
Abstract Objective To investigate the application effect of Xuanyu Tongjing Decoction combined with gonadotropinreleasing hormone agonist(GnRH-a)in the postoperative patientswith ovarian endometriosis.Methods From January 2017 to January 2019,100 patients with ovarian endometriosis (stageⅢ-Ⅳ)treated by laparoscopic surgery in our hospital were selected as the research objects,and they were divided into observation group (50 cases)and control group(50 cases)according to the random number tablemethod.The patients in the control group were treated with Leuprolide,and the patients in the observation group were treated with Xuanyu Tongjing Decoction based on the control group.The clinical efficacy,sex hormones(estradiol[E2],luteinizing hormone[LH],follicle stimulating hormone[FSH])levels,symptom scores of traditional Chinesemedicine,dysmenorrhea score before and after treatment and incidence of adverse reactions were compared.Results The total effective rate of the observation group after treatment was higher than that of the control group,and the total incidence rate of adverse reactionswas lower than that of the control group,with statistically significant differences(P<0.05).The traditional Chinesemedicine symptom score,dysmenorrhea score and sex hormone levels after treatment of the observation group were lower than those of the control group,and the differences were statistically significant(P<0.05).Conclusion Xuanyu Tongjing Decoction combined with GnRH-a for postoperative patients with ovarian endometriosis can improve clinical efficacy,reduce traditional Chinese medicine syndrome score and pain score,improve sex hormone levels,and reduce the adverse reactions caused by long-term single administration of GnRH-a drugs,with better therapeutic effect.
|
|
|
|
|
[1] |
张文,冷金花.腹壁子宫内膜异位症诊断和治疗的研究进展[J].现代妇产科进展,2019,28(5):391-392.
|
[2] |
李秀菊.促性腺激素释放激素类似物联合腹腔镜手术治疗卵巢子宫内膜异位症的临床效果[J].河南医学研究,2019,28(9):1604-1605.
|
[3] |
赵飞燕.李维贤治疗痛经经验探究及虚寒痛经方的临床疗效观察[D].广州:广州中医药大学,2017.
|
[4] |
乐杰.妇产科学[M].6版.北京:人民卫生出版社,2004:356-358.
|
[5] |
罗颂平,谈勇.中医妇科学[M].2版.北京:人民卫生出版社,2012:246-251.
|
[6] |
田伟.中药新药临床研究指导原则[M].北京:人民卫生出版社,2011:240-241.
|
[7] |
王蔚文.临床疾病诊断与疗效判断标准[M].北京:科学技术文献出版社,2010:930.
|
[8] |
郎景和,崔恒,戴毅,等.2015年子宫内膜异位症的诊治指南专家解读[J.中华妇产科杂志,2017,52(12):857-861.
|
[9] |
石一复.医源性子宫内膜异位症的防治[J].中国实用妇科与产科杂志,2016,32(3):209-212.
|
[10] |
陈观美,徐莉莉,杨武.重度子宫内膜异位症术后GnRH-a与达英35联合治疗的疗效比较[J].重庆医学,2016,45(10):1387-1388.
|
[11] |
王敏,潘月,罗汝琼.GnRH-a联合腹腔镜手术治疗卵巢子宫内膜异位症的疗效及对卵巢储备功能的影响[J].中国妇幼保健,2018,33(8):1742-1744.
|
[12] |
张余芳,林尧,卢秀英,等.醋酸亮丙瑞林治疗子宫内膜异位症的临床观察[J].中国药房,2016,27(26):3675-3677.
|
[13] |
沈栗帆,何艳,季菲,等.醋酸亮丙瑞林对子宫内膜异位症内分泌水平及骨密度的影响[J].新疆医科大学学报,2017,40(2):170-173.
|
[14] |
祝敏捷,孙莲芳,杨静.温经汤治疗子宫内膜异位症的疗效及对机体免疫功能的影响[J].现代中西医结合杂志,2016,25(2):148-151.
|
[15] |
马桂琴.玄丹散结汤联合亮丙瑞林对子宫内膜异位症患者卵巢储备功能的影响[J].中国妇幼保健,2018,33(24):5912-5915.
|
[16] |
多晓玲,王桂芳.中药预处理对子宫内膜异位症的助孕效果观察[J].中国临床医生杂志,2017,45(12):95-97.
|
[17] |
魏玲,王军,张宗敏.宣郁通经汤与血府逐瘀胶囊治疗子宫内膜异位症痛经疗效观察[J].四川中医,2017,35(12):173-175.
|
[18] |
曾艺文,刘霞,刘耀岽.宣郁通经汤合少腹逐瘀汤加减治疗子宫内膜异位症痛经48例总结[J].湖南中医杂志,2019,35(3):7-9.
|
[19] |
孙芯蕊.论宣郁通经汤加减治疗子宫内膜异位症痛经[J].内蒙古中医药,2017,36(13):8-9.
|
[20] |
邓丽娟.复发性子宫内膜异位症进行中药保留灌肠和米非司酮联合治疗的临床效果观察[J].中国临床研究,2019,11(8):113-115.
|
|
|
|